| |
| Device | Lacrosse NSE ALPHA Coronary Dilatation Catheter |
| Generic Name | Catheter, percutaneous transluminal coronary angioplasty (ptca), cutting/scoring |
| Applicant | NIPRO VASCULAR CORPORATION (formerly Goodman Co., Ltd.) 5f Kdx Nagoya Sakae Bldg., 4-5-3 Sakae, Naka-Ku Nagoya |
| PMA Number | P230026 |
| Date Received | 08/31/2023 |
| Decision Date | 06/06/2024 |
| Product Code |
NWX |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT04985773
|
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement The Lacrosse NSE ALPHA Coronary Dilatation Catheter is device is indicated for balloon dilatation of the stenotic portion of the coronary artery including both de novo and in-stent restenosis, for the purpose of improving myocardial perfusion. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling
|
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S001 S003 S004 S005 |